ZEAL:CPH
Zealand Pharma A/S
DKK 229.40
arrow_upward
+0.92%(+2.10) 1D
Okt 15, 5:00:00 PM GMT+2 · DKK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ZEAL...
Buksan
DKK 227.00
Mataas
DKK 229.40
Mababa
DKK 223.10
Mkt. cap
16.56B
Avg. na dami
402.85K
Dami
383.87K
Mataas nang 52-wk
DKK 556.00
Mababa nang 52-wk
DKK 223.10
Mga natitirang share
71.61M
Bilang ng mga empleyado
578
Buksan
DKK 227.00
Mataas
DKK 229.40
Mababa
DKK 223.10
Mkt. cap
16.56B
Avg. na dami
402.85K
Dami
383.87K
Mataas nang 52-wk
DKK 556.00
Mababa nang 52-wk
DKK 223.10
Mga natitirang share
71.61M
Bilang ng mga empleyado
578
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com Canada
·
2 araw ang nakalipas
Zealand Pharma partners with Generate on AI drug development By Investing.com
Stock Titan
·
2 araw ang nakalipas
Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs.
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Tungkol sa Zealand Pharma A/S